Minimally invasive approaches for en-bloc anatomical lung and chest wall resection.
Chest wall resection
minimally invasive surgery
robot-assisted thoracic surgery
robotic surgery
video-assisted thoracoscopic surgery.
Journal
Turk gogus kalp damar cerrahisi dergisi
ISSN: 1301-5680
Titre abrégé: Turk Gogus Kalp Damar Cerrahisi Derg
Pays: Turkey
ID NLM: 100887967
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
08
10
2022
accepted:
17
11
2022
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
The aim of this study was to evaluate the feasibility of Between January 2013 and December 2021, a total of 22 patients (18 males, 4 females; mean age: 63±6.9 years; range, 48 to 78 years) who underwent anatomical lung and chest wall resection using minimally invasive surgery for non-small cell lung cancer were retrospectively analyzed. Demographic, clinical, intra- and postoperative data of the patients, recurrence, metastasis, mortality, and overall survival rates were recorded. The surgical technique was robot-assisted thoracic surgery in two, multiport video-assisted thoracoscopic surgery in 18, and uniport video-assisted thoracoscopic surgery in two patients. Upper lobectomy was performed in 17 (77.3%) patients, lower lobectomy in three (13.6%) patients, and upper lobe segmentectomy in two (9.1%) patients. Five different techniques were used for chest wall resection. Nine (40.9%) patients had one, eight (36.4%) patients had two, four (18.2%) patients had three, and one (4.5%) patient had four rib resections. Chest wall reconstruction was necessary for only one of the patients. The mean operation time was 114±36.8 min. Complete resection was achieved in all patients. Complications were observed in seven (31.8%) patients without mortality. The mean follow-up was 24.4±17.9 months. The five-year overall survival rate was 55.3%. Segmentectomy/lobectomy and chest wall resection with minimally invasive surgery are safe and feasible in patients with nonsmall cell lung cancer. In addition, the localization of the area where chest wall resection would be performed should be considered the most crucial criterion in selecting the ideal technique.
Sections du résumé
Background
UNASSIGNED
The aim of this study was to evaluate the feasibility of
Methods
UNASSIGNED
Between January 2013 and December 2021, a total of 22 patients (18 males, 4 females; mean age: 63±6.9 years; range, 48 to 78 years) who underwent anatomical lung and chest wall resection using minimally invasive surgery for non-small cell lung cancer were retrospectively analyzed. Demographic, clinical, intra- and postoperative data of the patients, recurrence, metastasis, mortality, and overall survival rates were recorded.
Results
UNASSIGNED
The surgical technique was robot-assisted thoracic surgery in two, multiport video-assisted thoracoscopic surgery in 18, and uniport video-assisted thoracoscopic surgery in two patients. Upper lobectomy was performed in 17 (77.3%) patients, lower lobectomy in three (13.6%) patients, and upper lobe segmentectomy in two (9.1%) patients. Five different techniques were used for chest wall resection. Nine (40.9%) patients had one, eight (36.4%) patients had two, four (18.2%) patients had three, and one (4.5%) patient had four rib resections. Chest wall reconstruction was necessary for only one of the patients. The mean operation time was 114±36.8 min. Complete resection was achieved in all patients. Complications were observed in seven (31.8%) patients without mortality. The mean follow-up was 24.4±17.9 months. The five-year overall survival rate was 55.3%.
Conclusion
UNASSIGNED
Segmentectomy/lobectomy and chest wall resection with minimally invasive surgery are safe and feasible in patients with nonsmall cell lung cancer. In addition, the localization of the area where chest wall resection would be performed should be considered the most crucial criterion in selecting the ideal technique.
Identifiants
pubmed: 37664764
doi: 10.5606/tgkdc.dergisi.2023.23850
pmc: PMC10472457
doi:
Types de publication
Journal Article
Langues
eng
Pagination
374-380Informations de copyright
Copyright © 2023, Turkish Society of Cardiovascular Surgery.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Références
Ann Thorac Surg. 2000 Dec;70(6):2138-40
pubmed: 11156135
Innovations (Phila). 2013 Jan-Feb;8(1):70-2
pubmed: 23571797
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Jul 03;26(3):441-449
pubmed: 32082776
Eur J Cardiothorac Surg. 2014 May;45(5):787-98
pubmed: 24578407
Thorac Surg Clin. 2017 May;27(2):195-199
pubmed: 28363374
J Vis Surg. 2018 Mar 23;4:57
pubmed: 29682467
Lung Cancer. 2017 Feb;104:79-84
pubmed: 28213006
Eur J Cardiothorac Surg. 2014 Apr;45(4):633-9
pubmed: 24130372
Eur J Cardiothorac Surg. 2012 Apr;41(4):888-92
pubmed: 22219441
Ann Thorac Surg. 2015 Jun;99(6):1929-34; discussion 1934-5
pubmed: 25916876
J Vis Surg. 2017 May 25;3:73
pubmed: 29078636
J Thorac Cardiovasc Surg. 2012 Sep;144(3):S52-7
pubmed: 22743175
Ann Thorac Surg. 2010 Jun;89(6):S2142-5
pubmed: 20493998
Ann Thorac Surg. 2005 Dec;80(6):2032-40
pubmed: 16305839
Interact Cardiovasc Thorac Surg. 2013 Jul;17(1):32-5
pubmed: 23592724
Gen Thorac Cardiovasc Surg. 2018 Nov;66(11):626-631
pubmed: 30062622